NASDAQ:VIST - Visterra Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started Previous CloseN/AToday's RangeN/A52-Week RangeN/AVolumeN/AAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/ABetaN/A ProfileDiscussionChartFinancialsHeadlinesSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Visterra Inc is a United States-based biotechnology company. The Company uses its Atomic Interaction Network analysis to identify disease targets and design effective therapeutics. The Company's technology is based on its Hierotope Platform, which identifies an area, or epitope, on the target protein, glycoprotein or glycan that is fundamental to its structure and function. The Company's Hierotope Platform is able to identify the region of the protein, or epitope, which is structurally constrained, and thus prevented from mutation over time or under immunological or therapeutic pressure. Its technology for creating potent and therapeutics is powered by the Company's computational tools and techniques, the core of which is called Atomic Interaction Network (AIN) analysis. Receive VIST News and Ratings via Email Sign-up to receive the latest news and ratings for VIST and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NASDAQ Industry N/A Sub-IndustryN/A SectorN/A Current SymbolNASDAQ:VIST Previous Symbol CUSIPN/A CIK775662 Webwww.visterrainc.com Phone+1-617-4981070Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding SharesN/AMarket CapN/A Next Earnings DateN/A OptionableNot Optionable Visterra (NASDAQ:VIST) Frequently Asked Questions What is Visterra's stock symbol? Visterra trades on the NASDAQ under the ticker symbol "VIST." Has Visterra been receiving favorable news coverage? News stories about VIST stock have trended negative on Tuesday, according to InfoTrie Sentiment. The research firm identifies positive and negative media coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Visterra earned a coverage optimism score of -2.0 on InfoTrie's scale. They also gave headlines about the biotechnology company a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an effect on the stock's share price in the next few days. When did Visterra IPO? (VIST) raised $51 million in an initial public offering (IPO) on the week of January 30th 2017. The company issued 3,900,000 shares at $12.00-$14.00 per share. Leerink Partners and Stifel served as the underwriters for the IPO and Needham & Company, Wedbus and PacGrow were co-managers. How do I buy shares of Visterra? Shares of VIST can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Visterra's official website? The official website for Visterra is http://www.visterrainc.com/. How can I contact Visterra? Visterra's mailing address is 1 Kendall Sq Ste B3301, CAMBRIDGE, MA 02139-1604, United States. The biotechnology company can be reached via phone at +1-617-4981070. MarketBeat Community Rating for Visterra (NASDAQ VIST)Community Ranking: 1.9 out of 5 ()Outperform Votes: 32 (Vote Outperform)Underperform Votes: 51 (Vote Underperform)Total Votes: 83MarketBeat's community ratings are surveys of what our community members think about Visterra and other stocks. Vote "Outperform" if you believe VIST will outperform the S&P 500 over the long term. Vote "Underperform" if you believe VIST will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 3/26/2019 by MarketBeat.com StaffFeatured Article: Should you buy a closed-end mutual fund?